Skip to content

Effectiveness of Shockwave Therapy vs Handheld Vibration in Treating Upper Trapezius Trigger Points

comparison of the efficacy of extracorporeal shockwave therapy and handheld vibrator on trigger point of upper trapezius in myofascial pain syndrome: a randomized clinical trial. - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/105527
Enrollment
32
Registered
2026-03-06
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M791- Myalgia

Interventions

Intervention1: Extracorporeal Shockwave Therapy: Participants will receive extracorporeal shockwave therapy applied to the upper-trapezius trigger point using an electro-pneumatic device (3000 pulses/
1.3 1.5 bar
6 10 Hz). Treatment will be given 2 sessions/week for 3 weeks (6 sessions). All participants will also follow a standardized clinic exercise and home exercise program with ergonomic advice. Control In

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants with a trigger point in the upper trapezius muscle in MPS (diagnosis based on criteria made by 2 physiatrists Travell and Simons. that is a well-defined tender hypersensitive palpable nodule located within a taut band of the upper trapezius muscle typically referred to as pain patterns and LTR(Local Twitch Response ) elicited by snapping palpation of the TrP) Onset of pain within 3 months A more painful side will be included in the study (either left or right) Mild to moderate pain intensity at baseline (VAS pain between 3 and 6) Subjects who have not received any treatment for their symptoms in the last 1 month

Exclusion criteria

Exclusion criteria: Neurological conditions such as cervical disc disorder (radiculopathy herniation myelopathy) or stroke and Parkinsons disease Diagnosed cases of musculoskeletal conditions like rotator cuff tendinitis neck and upper back fracture shoulder impingement syndrome and upper limb deformity (fixed contracture or deformities of the shoulder and neck) Rheumatological diseases like rheumatoid arthritis and ankylosing spondylitis Heart diseases Patient with a pacemaker Pregnant women or breastfeeding women Any drug therapy or anticoagulant therapy Presence of skin infection Has the participant received any local anesthesia Severe psychiatric problem Participants with a bleeding tendency Red flag signs like malignancy and vascular disease Surgical history of cervical and shoulder

Design outcomes

Primary

MeasureTime frame
Pain Pressure Threshold AlgometerTimepoint: Baseline and after 3 weeks

Secondary

MeasureTime frame
Visual Analogous Scale Universal Goniometer Neck Disability IndexTimepoint: 2 Points(baseline and 3 weeks)

Countries

India

Contacts

Public ContactDr Mr K Ramprabhu PT

Pandit Deendayal Upadhyaya National Institute for Persons with Physical Disabilities (Divyangjan)

ramp76@rediffmail.com919818885324

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026